Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis
Copyright © 2024. Published by Elsevier Inc..
BACKGROUND: Pulmonary hypertension (PH) is a heterogeneous disease with poor prognosis. Accurate risk stratification is essential for guiding treatment decisions in pulmonary arterial hypertension (PAH). While various risk models were developed for PAH, their comparative prognostic potential requires further exploration. Additionally, the applicability of risk scores in PH groups beyond group 1 remains to be investigated.
RESEARCH QUESTION: Are risk scores originally developed for PAH predictive in PH group 1-4?.
STUDY DESIGN AND METHODS: We conducted a comprehensive analysis of outcomes among incident PH patients enrolled in the multicenter worldwide PVRI-GoDeep meta-registry. Analyses were performed across PH groups 1-4 and further subgroups to evaluate the predictive value of PAH-risk scores, including REVEAL Lite 2, REVEAL 2.0, ESC/ERS 2022, COMPERA 3-strata and COMPERA 4-strata.
RESULTS: 8565 patients were included in the study, of whom 3537 patients were assigned to group 1 PH while 1807, 1635, and 1586 patients were diagnosed with group 2, group 3, and group 4 PH. Pulmonary hemodynamics were impaired with median mPAP of 42 [33,52]mmHg and PVR of 7 [4,11]WU. All risk scores were prognostic in the entire PH population and in each of the PH groups 1-4. The REVEAL scores, when used as continuous prediction models, possessed the highest statistical prognostic power and granularity; the COMPERA 4-strata risk score provided sub-differentiation of the intermediate-risk group. Similar results were obtained when separately analyzing various subgroups (PH subgroups 1.1, 1.4.1, 1.4.4; 3.1, 3.2; group 2 with isolated post-capillary-PH versus combined pre-/post-capillary-PH; patients of all groups with concomitant cardiac comorbidities; severe [> 5 WU] versus non-severe PH).
INTERPRETATION: This comprehensive study with real-world data from 15 PH-centers showed that PAH-designed risk scores possess predictive power in a large PH cohort, whether considered as common group or calculated separately for each PH group (1-4) and various subgroups.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Chest - (2024) vom: 18. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yogeswaran, Athiththan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 22.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.chest.2024.03.018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369979133 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369979133 | ||
| 003 | DE-627 | ||
| 005 | 20240323001333.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.chest.2024.03.018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM369979133 | ||
| 035 | |a (NLM)38508334 | ||
| 035 | |a (PII)S0012-3692(24)00309-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yogeswaran, Athiththan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a BACKGROUND: Pulmonary hypertension (PH) is a heterogeneous disease with poor prognosis. Accurate risk stratification is essential for guiding treatment decisions in pulmonary arterial hypertension (PAH). While various risk models were developed for PAH, their comparative prognostic potential requires further exploration. Additionally, the applicability of risk scores in PH groups beyond group 1 remains to be investigated | ||
| 520 | |a RESEARCH QUESTION: Are risk scores originally developed for PAH predictive in PH group 1-4? | ||
| 520 | |a STUDY DESIGN AND METHODS: We conducted a comprehensive analysis of outcomes among incident PH patients enrolled in the multicenter worldwide PVRI-GoDeep meta-registry. Analyses were performed across PH groups 1-4 and further subgroups to evaluate the predictive value of PAH-risk scores, including REVEAL Lite 2, REVEAL 2.0, ESC/ERS 2022, COMPERA 3-strata and COMPERA 4-strata | ||
| 520 | |a RESULTS: 8565 patients were included in the study, of whom 3537 patients were assigned to group 1 PH while 1807, 1635, and 1586 patients were diagnosed with group 2, group 3, and group 4 PH. Pulmonary hemodynamics were impaired with median mPAP of 42 [33,52]mmHg and PVR of 7 [4,11]WU. All risk scores were prognostic in the entire PH population and in each of the PH groups 1-4. The REVEAL scores, when used as continuous prediction models, possessed the highest statistical prognostic power and granularity; the COMPERA 4-strata risk score provided sub-differentiation of the intermediate-risk group. Similar results were obtained when separately analyzing various subgroups (PH subgroups 1.1, 1.4.1, 1.4.4; 3.1, 3.2; group 2 with isolated post-capillary-PH versus combined pre-/post-capillary-PH; patients of all groups with concomitant cardiac comorbidities; severe [> 5 WU] versus non-severe PH) | ||
| 520 | |a INTERPRETATION: This comprehensive study with real-world data from 15 PH-centers showed that PAH-designed risk scores possess predictive power in a large PH cohort, whether considered as common group or calculated separately for each PH group (1-4) and various subgroups | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a PVRI GoDeep meta-registry | |
| 650 | 4 | |a multicentric | |
| 650 | 4 | |a predictive power | |
| 650 | 4 | |a pulmonary hypertension | |
| 650 | 4 | |a risk stratification | |
| 700 | 1 | |a Gall, Henning |e verfasserin |4 aut | |
| 700 | 1 | |a Fünderich, Meike |e verfasserin |4 aut | |
| 700 | 1 | |a Wilkins, Martin R |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, Luke |e verfasserin |4 aut | |
| 700 | 1 | |a Kiely, David G |e verfasserin |4 aut | |
| 700 | 1 | |a Lawrie, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a Hassoun, Paul M |e verfasserin |4 aut | |
| 700 | 1 | |a Sirenklo, Yuriy |e verfasserin |4 aut | |
| 700 | 1 | |a Torbas, Olena |e verfasserin |4 aut | |
| 700 | 1 | |a Sweatt, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Zamanian, Roham T |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Paul G |e verfasserin |4 aut | |
| 700 | 1 | |a Frauendorf, Marlize |e verfasserin |4 aut | |
| 700 | 1 | |a Arvanitaki, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Giannakoulas, George |e verfasserin |4 aut | |
| 700 | 1 | |a Saleh, Khaled |e verfasserin |4 aut | |
| 700 | 1 | |a Sabbour, Hani |e verfasserin |4 aut | |
| 700 | 1 | |a Cajigas, Hector R |e verfasserin |4 aut | |
| 700 | 1 | |a Frantz, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Al Ghouleh, Imad |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Stephen Y |e verfasserin |4 aut | |
| 700 | 1 | |a Brittain, Evan |e verfasserin |4 aut | |
| 700 | 1 | |a Annis, Jeffrey S |e verfasserin |4 aut | |
| 700 | 1 | |a Pepe, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Ghio, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Orfanos, Stylianos |e verfasserin |4 aut | |
| 700 | 1 | |a Anthi, Anastasia |e verfasserin |4 aut | |
| 700 | 1 | |a Majeed, Raphael W |e verfasserin |4 aut | |
| 700 | 1 | |a Wilhelm, Jochen |e verfasserin |4 aut | |
| 700 | 1 | |a Ghofrani, Hossein Ardeschir |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Manuel J |e verfasserin |4 aut | |
| 700 | 1 | |a Grimminger, Friedrich |e verfasserin |4 aut | |
| 700 | 1 | |a Sahay, Sandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Tello, Khodr |e verfasserin |4 aut | |
| 700 | 1 | |a Seeger, Werner |e verfasserin |4 aut | |
| 700 | 0 | |a PVRI-GoDeep-Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Antoine, Tobiah |e investigator |4 oth | |
| 700 | 1 | |a Backofen, Achim |e investigator |4 oth | |
| 700 | 1 | |a Cannon, John |e investigator |4 oth | |
| 700 | 1 | |a Damonte, Victoria |e investigator |4 oth | |
| 700 | 1 | |a Echazarreta, Diego |e investigator |4 oth | |
| 700 | 1 | |a Eichstaedt, Christina |e investigator |4 oth | |
| 700 | 1 | |a Elwing, Jean |e investigator |4 oth | |
| 700 | 1 | |a Förster, Kai |e investigator |4 oth | |
| 700 | 1 | |a Gruenig, Ekkehard |e investigator |4 oth | |
| 700 | 1 | |a Hilgendorff, Anne |e investigator |4 oth | |
| 700 | 1 | |a Jose, Arun |e investigator |4 oth | |
| 700 | 1 | |a Junaeda, Ernesto |e investigator |4 oth | |
| 700 | 1 | |a Krieb, Philipp |e investigator |4 oth | |
| 700 | 1 | |a Marquardt, Kurt |e investigator |4 oth | |
| 700 | 1 | |a Osborn, Karen |e investigator |4 oth | |
| 700 | 1 | |a Pepke-Zaba, Johanna |e investigator |4 oth | |
| 700 | 1 | |a Tilea, Ioan |e investigator |4 oth | |
| 700 | 1 | |a Varga, Andreea |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Chest |d 1970 |g (2024) vom: 18. März |w (DE-627)NLM000002720 |x 1931-3543 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:18 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.chest.2024.03.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 18 |c 03 | ||